Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide Diskus Compliance Training in Asthma
NCT00351143Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of salmeterol + fluticasone in asthma (2 arms), sponsored by GSK. Primary endpoint: Number of subjects who achieved Total asthma Control at 24 weeks. Started Jul 2005; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00351143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351143.